CORT logo

CORT
Corcept Therapeutics Inc

4,443
Mkt Cap
$4.11B
Volume
1.86M
52W High
$117.33
52W Low
$32.99
PE Ratio
41.74
CORT Fundamentals
Price
$36.53
Prev Close
$37.00
Open
$36.50
50D MA
$73.92
Beta
1.20
Avg. Volume
1.98M
EPS (Annual)
$1.23
P/B
6.08
Rev/Employee
$1.35M
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors...
PR Newswire·18h ago
News Placeholder
More News
News Placeholder
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman
Corcept Therapeutics (CORT) Faces Investor Scrutiny Amid Receipt of FDA Complete Response Letter For Relacorilant, Shares Tank 50% - Hagens Berman Corcept Therapeutics (CORT) Faces Investor Scrutiny...
PR Newswire·3d ago
News Placeholder
Corcept Therapeutics (NASDAQ:CORT) Shares Down 6.9% Following Analyst Downgrade
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 6.9% After Analyst Downgrade...
MarketBeat·4d ago
News Placeholder
Corcept (CORT) Surges 9.8%: Is This an Indication of Further Gains?
Corcept (CORT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·4d ago
News Placeholder
What is HC Wainwright's Estimate for CORT FY2030 Earnings?
Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) - Research analysts at HC Wainwright issued their FY2030 EPS estimates for Corcept Therapeutics in a research note issued to investors on...
MarketBeat·4d ago
News Placeholder
Synergy Asset Management LLC Raises Position in Corcept Therapeutics Incorporated $CORT
Synergy Asset Management LLC increased its stake in Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 96.1% during the third quarter, according to its most recent filing with the...
MarketBeat·6d ago
News Placeholder
Corcept Therapeutics (NASDAQ:CORT) Trading Up 9.7% - Here's What Happened
Corcept Therapeutics (NASDAQ:CORT) Stock Price Up 9.7% - Still a Buy...
MarketBeat·7d ago
News Placeholder
Corcept Tanks on FDA's CRL to Relacorilant NDA in Hypercortisolism
CORT's shares plunge after the FDA issues a CRL to relacorilant's new drug application for treating patients with hypercortisolism.
Zacks·7d ago
News Placeholder
Implied Volatility Surging for Corcept Stock Options
Investors need to pay close attention to CORT stock based on the movements in the options market lately.
Zacks·7d ago
News Placeholder
Corcept Therapeutics (NASDAQ:CORT) Given New $99.00 Price Target at Canaccord Genuity Group
Canaccord Genuity Group reduced their price target on shares of Corcept Therapeutics from $140.00 to $99.00 and set a "buy" rating on the stock in a research report on Friday...
MarketBeat·7d ago
<
1
2
...
>

Latest CORT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.